medRxiv Preprints

{
  "doi": "10.1101/2024.09.26.24313895",
  "url": "https://www.medrxiv.org/content/10.1101/2024.09.26.24313895v2",
  "title": "Loss-of-function of RNA-binding protein PRRC2B causes translational defects and cardiovascular malformation",
  "source": "medrxiv",
  "authors": "Das, D.; Ivanov, A.; Khor, E.-S.; Jiang, F.; Yang, L.; Zhou, S.; He, J.; Kawakami, Y.; Wainwright, L.; Geiger, J.; Meng, F.; Liu, H.; Jin, Z.; Porter, G.; Murphy, P. J.; Yao, P.",
  "version": "2",
  "abstract": "Alternative splicing of pre-mRNA generates variant protein forms from a given gene, accounting for both functional redundancy and diversification. A novel RNA-binding protein, Pro-rich Coiled-coil Containing Protein 2B (PRRC2B), has been shown to mediate both upstream (u)ORF-dependent and independent regulation of translation initiation, which is essential for cell cycle progression and proliferation. We identified two alternative spliced isoforms of PRRC2B mRNA in human and mouse hearts, as well as in multiple cell types: the full-length and the exon 16-excluded isoform {triangleup}E16. A congenital heart disease-associated human mutation-mimicking knock-in of the equivalent variant in the mouse genome results in the depletion of full-length Prrc2b mRNA, but not the alternative spliced truncated form {triangleup}E16. This mouse model does not cause any apparent structural or functional cardiac disorders. In contrast, global genetic inactivation of the Prrc2b gene in the mouse genome, nullifying both mRNA isoforms, caused patent ductus arteriosus (PDA) and neonatal lethality. Bulk and single-nucleus transcriptome profiling analyses of embryonic mouse hearts at E18.5 demonstrate a s",
  "category": "cardiovascular medicine",
  "published_at": "2026-07-28T00:00:00.000Z",
  "corresponding_author": "Peng Yao",
  "journal_published_doi": null,
  "corresponding_institution": "Aab Cardiovascular Research Institute, Department of Medicine, Department of Biochemistry & Biophysics, The Center for RNA Biology, University of Rochester Scho"
}

{
  "doi": "10.64898/2026.07.24.26358894",
  "url": "https://www.medrxiv.org/content/10.64898/2026.07.24.26358894v2",
  "title": "Dual foundation models for accelerometry predict future health",
  "source": "medrxiv",
  "authors": "Dige, M.; Lorenzen, N. R.; Kjer, M. R.; Burns, A. C.; Jennum, P. J.; During, E. H.; Zou, J.; Mignot, E.; Brink-Kjaer, A.",
  "version": "2",
  "abstract": "Wrist accelerometers are ubiquitous and capture activity, sleep, and cardiorespiratory motion, but how this relates to future disease across the phenome is unclear. We encoded one week of UK Biobank accelerometry from 97,696 participants using two frozen self-supervised models and trained a multilabel survival model on these embeddings with participant age and sex for 390 outcomes. In 5,253 held-out participants, mean concordance was 0.688. A single component explained 76% of predicted risk variance and was associated with future disease burden and mortality. Nevertheless, disease-specific scores added discrimination beyond this shared axis for 85 of 101 well-powered outcomes. A higher-powered full-cohort out-of-fold analysis identified prodromal neurodegenerative signatures, strongest for Parkinson's disease (five-year time-dependent AUROC 0.90; 428 cases), with limited attenuation after lead-time washout. Daytime movement contributed most, whereas sleep-related and genetic information contributed selectively. These findings establish one week of wrist movement as a scalable, low-cost representation of future health for wearable-based risk assessment.",
  "category": "health informatics",
  "published_at": "2026-07-28T00:00:00.000Z",
  "corresponding_author": "Andreas Brink-Kjaer",
  "journal_published_doi": null,
  "corresponding_institution": "Technical University of Denmark"
}

{
  "doi": "10.64898/2026.07.22.26358733",
  "url": "https://www.medrxiv.org/content/10.64898/2026.07.22.26358733v1",
  "title": "Digital Health Adoption, eHealth Literacy, and Trust in AI Among Generation Z University Students in Sri Lanka: An Empirical Study",
  "source": "medrxiv",
  "authors": "Athukorala, S. C.",
  "version": "1",
  "abstract": "BackgroundDigital health technologies--spanning mobile applications, telemedicine, and AI-driven platforms--are rapidly reshaping healthcare delivery globally. Although Generation Z university students are classified as digital natives, empirical data evaluating their eHealth literacy, technology acceptance, and specific trust barriers in developing South Asian nations like Sri Lanka remain scarce. ObjectiveThis study evaluated eHealth literacy, technology acceptance, online health information-seeking behaviors, and adoption barriers among Gen Z undergraduates in Sri Lanka, focusing on the interplay between eHealth literacy, AI trust, and digital care preferences. MethodsA cross-sectional survey (N = 172) was conducted among Sri Lankan university undergraduates utilizing adapted, validated instruments: the eHealth Literacy Scale (eHEALS) and the Technology Acceptance Model (TAM). Statistical analysis included scale reliability validation (Cronbachs alpha), descriptive profiling, Chi-Square ({chi}2) contingency tests, Pearson correlations, and Multiple Linear OLS Regression models. ResultsParticipants demonstrated high overall eHealth literacy (Mean = 3.84 {+/-} 0.58) and strong end",
  "category": "health informatics",
  "published_at": "2026-07-28T00:00:00.000Z",
  "corresponding_author": "Susith  Chandima Athukorala",
  "journal_published_doi": null,
  "corresponding_institution": "Postgraduate Institute of Medicine University of Colombo"
}

{
  "doi": "10.64898/2026.07.23.26358767",
  "url": "https://www.medrxiv.org/content/10.64898/2026.07.23.26358767v1",
  "title": "Occupational Physical Activity Paradox and Incident Cardiovascular Disease: Does Exposure Classification Matter?",
  "source": "medrxiv",
  "authors": "Okoro, W. O.; Demou, E.; Celis-Morales, C. A.; Ryde, G. C.",
  "version": "1",
  "abstract": "ObjectivesThe association between occupational physical activity (OPA) and cardiovascular disease (CVD) may depend on how OPA is classified. This study examined the association between OPA and incident CVD using individual-level and occupational-group-level classifications, and assessed whether factors contributing to attenuation differed. MethodsA total of 137,592 employed UK Biobank participants aged 40-69 years who were free of CVD at baseline were included. OPA was classified using (i) individual-level self-reported physical activity at work and (ii) occupational-group-level two-digit Standard Occupational Classification. Associations with incident CVD were examined using Cox proportional hazards models. Attenuation of associations by sociodemographic, lifestyle, health, occupational and psychosocial factors was assessed using univariate adjustments and Hellers coefficient. ResultsDuring 1,656,378 person-years of follow-up (median 12.6 years), 10,465 incident CVD events occurred. The association between OPA and CVD differed markedly according to exposure classification. High individual-level self-reported OPA was associated with increased CVD incidence after full adjustment [ha",
  "category": "occupational and environmental health",
  "published_at": "2026-07-27T00:00:00.000Z",
  "corresponding_author": "Gemma Cathrine Ryde",
  "journal_published_doi": null,
  "corresponding_institution": "University of Glasgow"
}

{
  "doi": "10.64898/2026.01.02.25343170",
  "url": "https://www.medrxiv.org/content/10.64898/2026.01.02.25343170v6",
  "title": "Environmental lead exposure and preeclampsia in sub-Saharan Africa: modelling the potential contribution to maternal disease burden and opportunities for prevention",
  "source": "medrxiv",
  "authors": "Laidlaw, M. A. S.",
  "version": "6",
  "abstract": "BackgroundPreeclampsia is a leading cause of maternal morbidity and mortality in sub-Saharan Africa (SSA). Lead exposure remains widespread, yet its contribution to preeclampsia risk has not been quantified at the population level. In 2023, SSA accounted for [~]182,000 maternal deaths ({approx}70% of global deaths), with [~]16% attributed to hypertensive disorders of pregnancy--equivalent to [~]29,000 deaths annually. MethodsMaternal blood lead level (BLL) data from SSA pregnancy biomonitoring studies were synthesised and supplemented with soil-derived exposure scenarios representing highly contaminated settings. Using meta-analytic evidence indicating a 1.6% increase in preeclampsia odds per 1 {micro}g/dL increase in BLL, we modelled relative odds and predicted absolute risk across plausible baseline prevalence assumptions. Sensitivity analyses assessed uncertainty, and population attributable fractions (PAFs) were estimated. ResultsObserved BLLs were associated with modest but consistent increases in predicted preeclampsia risk. Severe exposure scenarios produced sharply elevated risks. Estimated PAFs were [~]6-8% at 5 {micro}g/dL, 19-21% at 15 {micro}g/dL, and 41-47% at 40 {micr",
  "category": "obstetrics and gynecology",
  "published_at": "2026-07-27T00:00:00.000Z",
  "corresponding_author": "Mark Andrew Scott Laidlaw",
  "journal_published_doi": null,
  "corresponding_institution": "Independent Researcher"
}

{
  "doi": "10.64898/2026.07.24.26358856",
  "url": "https://www.medrxiv.org/content/10.64898/2026.07.24.26358856v1",
  "title": "Population-level trends of Psychiatric Medication Co-Prescriptions in Persons with Epilepsy: an EPIC Cosmos Study",
  "source": "medrxiv",
  "authors": "Kostan, H.; Krishnan, V.",
  "version": "1",
  "abstract": "Persons with epilepsy (PWE) experience high rates of psychiatric comorbidity, yet the population-scale pharmacoepidemiology of psychiatric medication (PM) use alongside antiseizure medications (ASMs) has not been previously characterized. Using Epic Cosmos, a federated electronic health record network spanning >300 million patients across >2,000 hospital systems, we examined patterns of ASM and PM co-prescriptions in PWE (ICD-10 G40.x) every year between 2018-2025. PM prescriptions were similarly assessed in patients with asthma (J45.x). We found that despite the introduction of several newer ASMs, the overall prescribing landscape remained stable, with little change in the relative use of individual ASMs over time. Compared with asthma patients, PWE were more likely to receive prescriptions for opiates, antidepressant and antipsychotic medications across the age spectrum. [≤]17-year-old PWE were more likely to receive ADHD/stimulant medications, whereas adults and older adults exhibited a shift toward cognitive enhancing agents. We did not observe a preponderance of PM co-prescribing with any specific ASM or ASM class. Together, these results provide a population-scale, age-spe",
  "category": "neurology",
  "published_at": "2026-07-27T00:00:00.000Z",
  "corresponding_author": "Vaishnav Krishnan",
  "journal_published_doi": null,
  "corresponding_institution": "Baylor College of Medicine"
}

{
  "doi": "10.64898/2026.07.24.26358802",
  "url": "https://www.medrxiv.org/content/10.64898/2026.07.24.26358802v1",
  "title": "Noise is the signal: variability in surveillance data provide early indication of epidemic phase",
  "source": "medrxiv",
  "authors": "Moran, E. J.; Hill, D. T.; Alazawi, M.; Larsen, D. A.",
  "version": "1",
  "abstract": "Predicting epidemic surges is challenging and often relies on prior seasons, outbreaks in other regions, and advanced modeling of surveillance data. Using foundational principles of disease growth and spread, including trend analysis and overdispersion, we developed a surge detection algorithm for emerging pathogens that requires no historical baselines or seasonal assumptions. We used it to evaluate temporal variability (coefficient of variation, CV) and spatial clustering (global Morans I) as early warning indicators across three parallel SARS-CoV-2 surveillance streams: wastewater, clinical cases, and hospitalizations. All metrics showed consistent variability patterns across epidemic phases that predicted surge onset and decline approximately one month in advance. For weekly pre-surge detection, sensitivity and positive predictive value reached 75% and 54%. CV additionally signaled surge termination, with up to 70% sensitivity and 59% positive predictive value. When evaluated per surge, by requiring only a single correct signal within each phase, CV detected 86-98% of onsets and 73-85% of terminations. These signatures held across surveillance streams and geographic scales, sug",
  "category": "epidemiology",
  "published_at": "2026-07-27T00:00:00.000Z",
  "corresponding_author": "David Aaron Larsen",
  "journal_published_doi": null,
  "corresponding_institution": "Syracuse University"
}

{
  "doi": "10.64898/2026.07.23.26358833",
  "url": "https://www.medrxiv.org/content/10.64898/2026.07.23.26358833v1",
  "title": "Developing intrinsic capacity measures for research and practice in an Australian context",
  "source": "medrxiv",
  "authors": "Wang, J.; Clare, P.; Naganathan, V.; Ding, D.; Cesari, M.; Cullati, S.; Byles, J.; Blyth, F. M.; Khalatbari-Soltani, S.",
  "version": "1",
  "abstract": "Introduction: Intrinsic capacity is a key construct for healthy ageing; however, its measurement remains heterogeneous, with insufficient attention to context, data availability, and intended purpose. We operationalised intrinsic capacity to facilitate its assessment in both research and clinical settings. Method: Using data from Concord Health and Ageing in Men Project (CHAMP; 2005-2007; 1,705 Australian men aged [&ge;]70 years), we developed three intrinsic capacity models using confirmatory factor analysis (CFA): literature-based (21 commonly used indicators), minimum-set (10 indicators), and clinically informed (10 indicators selected for clinical feasibility). Convergent validity was assessed using activities of daily living (ADL) and instrumental activities of daily living (IADL) as indicators of functional ability. Predictive validity was examined using 2-year incident ADL and IADL dependency and 10-year mortality follow-up data. Results: All models demonstrated acceptable model fit (robust root mean square error of approximation <0.06). The second-order level of CFA showed significant associations with the cognition, locomotor function, psychological well-being, and vitalit",
  "category": "epidemiology",
  "published_at": "2026-07-27T00:00:00.000Z",
  "corresponding_author": "Saman Khalatbari-Soltani",
  "journal_published_doi": null,
  "corresponding_institution": "University of Sydney"
}

{
  "doi": "10.64898/2026.07.23.26358258",
  "url": "https://www.medrxiv.org/content/10.64898/2026.07.23.26358258v1",
  "title": "Comparison of Influenza Vaccine Effectiveness Estimates Using Test-Negative Prospective Enrollment and Electronic Health Record Data, United States, 2024--2025",
  "source": "medrxiv",
  "authors": "Price, A. M.; McLean, C.; Cleary, S.; Leis, A. M.; Vaughn, I. A.; House, S.; Ellsworth, S.; Moehling Geffel, K.; Taylor, L. H.; Gaglani, M.; Murthy, K.; Saade, E. A.; Ladikos, C.; Murugan, V.; Kramer, J. L.; Williamson, B. D.; Kiniry, E.; Walter, E. B.; Bontrager, N. A.; Ellington, S.; Flannery, B. M.; Chung, J.; US Flu VE Network Investigators,  ",
  "version": "1",
  "abstract": "Background: Influenza vaccine effectiveness (VE) is assessed annually through prospective enrollment of patients presenting with acute respiratory symptoms in a test-negative study design. Influenza VE has also been estimated from electronic health record (EHR) databases by linking medical diagnoses, laboratory test results, and patient influenza vaccination. There are limited data on agreement between influenza VE estimates from prospective enrollment versus EHR databases. Methods: The US Influenza Vaccine Effectiveness Network prospectively enrolled outpatients meeting clinical screening criteria and collected respiratory specimens to determine influenza virus infection. Seven study sites also identified EHR databases that included diagnostic codes for outpatient encounters associated with medically attended acute respiratory illness (MAARI), clinical respiratory virus testing, and influenza vaccination status. Effectiveness of influenza vaccination against laboratory-confirmed influenza was estimated from both data sources using logistic regression models including patient age, study site, and month of illness as 100(%) x (1 - adjusted odds ratio), comparing influenza vaccinatio",
  "category": "epidemiology",
  "published_at": "2026-07-27T00:00:00.000Z",
  "corresponding_author": "Ashley M Price",
  "journal_published_doi": null,
  "corresponding_institution": "Centers for Disease Control and Prevention"
}

{
  "doi": "10.64898/2026.07.23.26358748",
  "url": "https://www.medrxiv.org/content/10.64898/2026.07.23.26358748v1",
  "title": "Comparator supplement patterns qualify the clinical interpretation of an EHR-derived glucosamine signal in Alzheimer's disease",
  "source": "medrxiv",
  "authors": "Nakashima, S.; Sato, K.; Niimi, Y.; Satake, W.; Iwatsubo, T.",
  "version": "1",
  "abstract": "Electronic health records linked documented glucosamine use to faster progression from mild cognitive impairment (MCI) to Alzheimer's disease (AD) and poorer survival after dementia. We examined these associations in the National Alzheimer's Coordinating Center cohort and compared glucosamine with other supplement records captured in the same medication fields. The estimate for progression to primary AD dementia was in the same risk direction as the original finding, but similar estimates were observed for multivitamin/broad vitamin and calcium/vitamin D records. Among participants with dementia, glucosamine records were not associated with higher adjusted mortality, although death-data limitations reduce certainty. These findings do not address the experimental mechanism, but show that a glucosamine record alone does not establish a glucosamine-specific clinical effect.",
  "category": "epidemiology",
  "published_at": "2026-07-27T00:00:00.000Z",
  "corresponding_author": "Kenichiro Sato",
  "journal_published_doi": null,
  "corresponding_institution": "University of Tokyo Hospital"
}